Treatments
PRP, stem cell and laser-enhanced therapy, compared honestly
Premier offers three regenerative approaches for joint and tendon pain. Here is what each one is, what the research does and does not show, and who each may suit.
Self-pay treatment. Financing through Cherry available, subject to approval.
At a glance
- PRP comes first: it is the best studied and usually the lower cost option
- Cell-based injections are offered second, with their FDA status stated plainly
- Laser-enhanced care is an add-on, not a treatment on its own
- Injections are performed at Premier by licensed nurse practitioners, with care coordinated by a chiropractor-led team.
Option 1
PRP (platelet-rich plasma)
A small amount of your blood is drawn and spun in a centrifuge to concentrate the platelets, which carry growth factors. The concentrate is injected into the painful joint or tendon.
PRP is the most researched regenerative injection for knee arthritis and for tendon problems such as tennis elbow. Because it uses your own blood, prepared in the same visit, it avoids the questions that surround donor tissue products.
When it helps, improvement is often noticed in about 4 to 6 weeks and can keep building over several months. Some people notice little change.
Option 2
Umbilical cord (Wharton's jelly) cell injections
Often called stem cell therapy. Premier uses a product made from Wharton's jelly, the tissue inside donated umbilical cords, so nothing is collected from your body.
It can be used on its own or combined with PRP. Research is still limited: in the studies so far, cell-based injections have not been consistently better than PRP at 12 to 24 months, and combining the two has not been automatically better.
If you are considering it, ask the provider which product is used, where it comes from, the documentation behind it, the risks, and how the cost compares with PRP.
Option 3
Laser-enhanced therapy
The same cold laser (photobiomodulation) used in Premier's laser program, applied over the treated area at the injection visit or at follow-ups, at the provider's discretion.
It is an add-on to an injection plan, not a regenerative treatment on its own. Sessions are short.
Side by side
PRP vs stem cell therapy vs laser-enhanced care
| Feature | PRP | Umbilical cord cell injection | Laser-enhanced |
|---|---|---|---|
| Source | Your own blood, drawn at the visit | Donated umbilical cord tissue (Wharton's jelly) | Cold laser light over the area |
| How it is used | Injected into the joint or tendon | Injected alone or with PRP | Added at the visit or follow-ups, at the provider's discretion |
| Evidence | The most studied of the three | Limited; not shown to be consistently better than PRP | Supporting role only; evidence varies by condition |
| FDA status | Not FDA approved for orthopedic conditions; prepared with FDA cleared equipment | Not FDA approved for joint, tendon or spine conditions | Laser devices are cleared for specific uses; ask which |
| Visits | Often 1 to 3 injections, weeks apart | Usually 1 injection, plus follow-up | Several short sessions |
| Cost (national guide, not Premier's prices) | About $500 to $1,500 per injection | Averaged about $5,156 per knee in one US study | Quoted with your plan |
| Downtime | Soreness for a few days; usual activity soon after | Soreness for a few days | None expected |
Costs are national ranges for guidance (a 2017 study of 65 US clinics; common PRP pricing), not Premier's prices. Premier reviews costs with you before anything is booked.
The research
What the research does and does not show
What it shows
- PRP may reduce pain and improve function in mild to moderate knee osteoarthritis
- In a 2022 randomized trial (American Journal of Sports Medicine), people with knee arthritis reported improvement after both PRP and cell-based injections, with similar imaging results
- PRP has some of its stronger evidence in tennis elbow
What it does not show
- No consistent cartilage regrowth on MRI
- No consistent advantage of cord or cell products over PRP at 12 to 24 months
- No reliable benefit for advanced, bone-on-bone arthritis
Risks and cost
Before you decide
The most common effects are soreness, swelling and stiffness at the injection site for a few days. Less common risks include infection, bleeding and nerve irritation. Donor tissue products carry extra unknowns because research is limited.
Self-pay treatment. Financing through Cherry available, subject to approval. Insurance usually does not cover regenerative injections.
Two minutes, no obligation
See if regenerative care is worth a conversation
Answer a few questions about your pain and what you have tried. Our patient team reviews every answer personally and reaches out with honest next steps, including when these treatments are not the right fit.
Self-pay treatment. Financing through Cherry available, subject to approval.
